In December 2017, the US Food & Drug Administration (FDA) approved Luxturna from Spark Therapeutics — the first gene therapy to win market approval in the US. Several other gene therapy programs ...

The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...